Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

ASH 2021: Trial identifies five-drug combo for ‘ultra high risk’ bone marrow cancer

ASH 2021: Trial identifies five-drug combo for ‘ultra high risk’ bone marrow cancer

ASH 2021: Statistical models predict benefit of non-intensive AML therapy

ASH 2021: Statistical models predict benefit of non-intensive AML therapy

$ASH 2021: TRANSFORM study reports CAR T-cell therapy liso-cel significantly improves outcomes for relapsed and refractory large B-cell lymphoma$

ASH 2021: TRANSFORM study reports CAR T-cell therapy liso-cel significantly improves outcomes for relapsed and...

ASH 2021: Ivosidenib combined with azacitidine improves outcomes for newly diagnosed acute myeloid leukaemia with IDH-1 mutation compared with azacitidine alone

ASH 2021: Ivosidenib combined with azacitidine improves outcomes for newly diagnosed acute myeloid leukaemia with...

SABCS 2021: Tamoxifen may boost PI3K signalling to increase uterine cancer risk in patients with breast cancer

SABCS 2021: Tamoxifen may boost PI3K signalling to increase uterine cancer risk in patients with breast cancer

One in five future thyroid cancers linked to excess weight

One in five future thyroid cancers linked to excess weight

FDA approves pembrolizumab as adjuvant treatment for adult and paediatric patients with stage IIB or IIC melanoma

FDA approves pembrolizumab as adjuvant treatment for adult and paediatric patients with stage IIB or IIC melanoma

SABCS 2021: Single-cell spatial analysis may help predict response to neoadjuvant immunotherapy in triple-negative breast cancer

SABCS 2021: Single-cell spatial analysis may help predict response to neoadjuvant immunotherapy in triple-negative...

SABCS 2021: Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior endocrine therapy

SABCS 2021: Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior...

Study finds chemotherapy fails for some blood cancer patients because of crucial gene mutations

Study finds chemotherapy fails for some blood cancer patients because of crucial gene mutations

More from ecancer